Subcutaneous Administration of Teplizumab in Adults With Type 1 Diabetes
Clinical trial NCT01189422 · TERMINATED
Trial details
- NCT number
- NCT01189422
- Sponsor
- MacroGenics
- Status
- TERMINATED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2010-08-01
- Primary completion
- 2011-02-01
- Enrollment
- 1
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.